Congestive Heart Failure

aastrom

Aastrom Enrolls First Patients In Phase 2b Clinical Trial of Ixmyelocel-T

Aastrom Biosciences Inc. (Nasdaq:ASTM), the developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, today announced that the first patients have been enrolled in the ixCELL-DCM clinical trial.

WWJ Newsradio 950–04/04/2013

issys

ISSYS Gets Patent For Wireless, Implantable Hemodynamic Pressure Monitor

Integrated Sending Systems Inc, or ISSYS as the firm calls itself for short, announced Thursday that it had been granted United States Patent 8,014,865 titled “Method for Monitoring a Physiologic Parameter of Patients with Congestive Heart Failure.”

WWJ Newsradio 950–03/14/2013

The DuraHeart device.

German Patient Survives 5 Years With DuraHeart Assist Device

Ann Arbor-based Terumo Heart Inc., a wholly owned subsidiary of Japan’s Terumo Corp., Tuesday announced that a patient implanted with the DuraHeart Left Ventricular Assist System has surpassed five years of support on the mechanical circulatory support device.

WWJ Newsradio 950–07/19/2011

Follow

Get every new post delivered to your Inbox.

Join 2,354 other followers